662 related articles for article (PubMed ID: 34808697)
1. Growth hormone for in vitro fertilisation (IVF).
Sood A; Mohiyiddeen G; Ahmad G; Fitzgerald C; Watson A; Mohiyiddeen L
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD000099. PubMed ID: 34808697
[TBL] [Abstract][Full Text] [Related]
2. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
[TBL] [Abstract][Full Text] [Related]
3. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
[TBL] [Abstract][Full Text] [Related]
4. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
[TBL] [Abstract][Full Text] [Related]
5. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
6. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
Naik S; Lepine S; Nagels HE; Siristatidis CS; Kroon B; McDowell S
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD009749. PubMed ID: 38837771
[TBL] [Abstract][Full Text] [Related]
7. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.
Boomsma CM; Kamath MS; Keay SD; Macklon NS
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD005996. PubMed ID: 35771604
[TBL] [Abstract][Full Text] [Related]
8. Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle.
Glujovsky D; Pesce R; Miguens M; Sueldo C; Ciapponi A
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD013827. PubMed ID: 38032057
[TBL] [Abstract][Full Text] [Related]
9. Endometrial injury in women undergoing in vitro fertilisation (IVF).
Lensen SF; Armstrong S; Gibreel A; Nastri CO; Raine-Fenning N; Martins WP
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009517. PubMed ID: 34110001
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; Woolner A
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD005289. PubMed ID: 33844275
[TBL] [Abstract][Full Text] [Related]
11. Autologous platelet-rich plasma for assisted reproduction.
Vaidakis D; Papapanou M; Siristatidis CS
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013875. PubMed ID: 38682756
[TBL] [Abstract][Full Text] [Related]
12. Interventions for unexplained infertility: a systematic review and network meta-analysis.
Wang R; Danhof NA; Tjon-Kon-Fat RI; Eijkemans MJ; Bossuyt PM; Mochtar MH; van der Veen F; Bhattacharya S; Mol BWJ; van Wely M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012692. PubMed ID: 31486548
[TBL] [Abstract][Full Text] [Related]
13. Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.
Georgiou EX; Melo P; Baker PE; Sallam HN; Arici A; Garcia-Velasco JA; Abou-Setta AM; Becker C; Granne IE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31747470
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
15. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
Cornelisse S; Zagers M; Kostova E; Fleischer K; van Wely M; Mastenbroek S
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD005291. PubMed ID: 32898291
[TBL] [Abstract][Full Text] [Related]
16. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
17. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)).
Lacey L; Hassan S; Franik S; Seif MW; Akhtar MA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001894. PubMed ID: 33730422
[TBL] [Abstract][Full Text] [Related]
18. Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.
Cantineau AE; Rutten AG; Cohlen BJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD005356. PubMed ID: 34739136
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.
Franik S; Le QK; Kremer JA; Kiesel L; Farquhar C
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD010287. PubMed ID: 36165742
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
